Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

1.330 -0.040 (-2.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 984,938
Open 1.410
Bid (Size) 1.330 (6)
Ask (Size) 1.390 (2)
Prev. Close 1.370
Today's Range 1.311 - 1.455
52wk Range 0.3131 - 28.20
Shares Outstanding 10,299,385
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Applied DNA Sciences (APDN) Stock Is Skyrocketing
Applied DNA Sciences has expanded its mpox testing services. Shares rose 37% after the announcement. 
Via Benzinga
Applied DNA Launches Mpox Clade I and Clade II Testing Service
Via ACCESSWIRE

Performance

YTD
-89.28%
-89.28%
1 Month
-25.70%
-25.70%
3 Month
+189.13%
+189.13%
6 Month
-84.89%
-84.89%
1 Year
-95.07%
-95.07%

More News

Read More
Looking Into Applied DNA Sciences's Recent Short Interest
Via Benzinga
Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan
Via ACCESSWIRE
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
Via Benzinga
Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I
Via ACCESSWIRE
Looking Into Applied DNA Sciences's Recent Short Interest
Via Benzinga
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
Via ACCESSWIRE
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Via ACCESSWIRE
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I
Via ACCESSWIRE
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024
Via InvestorPlace
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
Via ACCESSWIRE
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Via ACCESSWIRE
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit
Via ACCESSWIRE
Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability
Via ACCESSWIRE
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.